This inventor holds 8 USPTO granted patents. Top assignees: Sri International, Stanford Research Institute. Active years: 1976-2000.
Location History:
- San Jose, CA (US) (1976)
- Yreka, CA (US) (1987 - 1992)
- Fresno, CA (US) (1998 - 2000)
Company Filing History:
Years Active: 1976-2000
Title: David F Crowe: Innovator in Antiandrogenic Agents
Introduction
David F Crowe is a notable inventor based in Fresno, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiandrogenic agents. With a total of 8 patents to his name, Crowe's work has the potential to impact various clinical conditions related to androgen levels.
Latest Patents
Among his latest patents is a method and composition for effecting contraception in a mammalian male. This innovative work provides novel antiandrogenic agents, which are characterized by a specific structural formula. The pharmaceutical compositions and methods outlined in this patent aim to treat androgen-related clinical conditions and offer new contraceptive options. Another significant patent focuses on the same area, emphasizing the importance of these compounds in medical applications.
Career Highlights
David F Crowe has had a distinguished career, working with reputable organizations such as SRI International and Stanford Research Institute. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Throughout his career, Crowe has worked alongside notable colleagues, including Masato Tanabe and Richard H Peters. These collaborations have further enriched his research and development efforts in the pharmaceutical industry.
Conclusion
David F Crowe's innovative work in the field of antiandrogenic agents showcases his dedication to advancing medical science. His patents reflect a commitment to addressing critical health issues and improving treatment options for patients.